RSS Feeds
Predicting Death in Mechanically Ventilated Recipients of Bone Marrow Transplants
- Gordon D. Rubenfeld, MD, MSc; and
- Stephen W. Crawford, MD
- Harborview Medical Center; Seattle, WA 98104-2499 Fred Hutchinson Cancer Research Center; Seattle, WA 98104
The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:
•Include no more than 300 words of text, three authors, and five references
•Type with double-spacing
•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.
Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.
Annals welcomes electronically submitted letters.
IN RESPONSE:
Hennessy and colleagues' experience of no survivors out of 21 mechanically ventilated patients is consistent with our findings and those reported in the literature. We note that the upper bound of the 95% CI in this small sample allows for a 16% survival rate in mechanically ventilated patients. It would be problematic to draw conclusions about the relation (or lack of a relation) between timing of respiratory failure after bone marrow transplantation and survival in a sample of 21 patients.
In our report we proposed guidelines for limiting life support in selected bone marrow transplant recipients on the basis of three principles: 1) prognostic indicators with high specificity and narrow CIs; 2) a process through which patients and their surrogates are informed of the risks of respiratory complications, the outcomes of mechanical ventilation, and the decision-making guidelines; and 3) an ongoing educational and quality improvement process to evaluate end-of-life decisions.
Most patients who eventually die meet one of the criteria for not surviving by day 4 of mechanical ventilation. The prognosis of patients who do not fulfill any of the criteria is 13.5%. For patients who consent, we therefore believe that a trial of mechanical ventilation is justified and that life support should be promptly withdrawn if the patient does not respond. Lack of response is manifested by hepatic and renal failure, lung injury, or hemodynamic instability requiring vasopressors.
Gordon D. Rubenfeld, MD, MSc
Harborview Medical Center; Seattle, WA 98104-2499
- Copyright ©2004 by the American College of Physicians
